Neogen Corporation ( NEOG) - Key Metrics
NEOG Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q1 | $1.02 | -$0.05 | $0.06 | $0.02 |
| 2026Q4 | $1.03 | -$0.05 | $0.14 | -$0.04 |
| 2026Q3 | $0.97 | -$0.08 | $0.10 | $0.05 |
| 2026Q2 | $1.03 | -$0.07 | $0.09 | $0.20 |
| 2026Q1 | $0.96 | $0.17 | $0.05 | -$0.06 |
NEOG Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q1 | 0% | -57.80 |
| 2026Q4 | 0% | -44.60 |
| 2026Q3 | 0% | -35.09 |
| 2026Q2 | 0% | -20.22 |
| 2026Q1 | 0% | 8.46 |
NEOG Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2027Q1 | 0.19% | 0% |
| 2026Q4 | -0.49% | 0% |
| 2026Q3 | 0.45% | 0% |
| 2026Q2 | 3.38% | 0% |
| 2026Q1 | -1.05% | 0% |
NEOG
Price: $12.26
52 week price:
Earnings Per Share: -0.26 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.5 million
Ebitda: 22.3 millionMarket Capitalization: 2.6 billion